Spero Therapeutics Inc (SPRO) Annual Balance Sheets

Annual · GAAP · USD millions
Access SPRO quarterly Balance Sheets →
A period-by-period view of the balance sheet from Spero Therapeutics Inc to Dec 31 2021 helps clarify how Dec 31 2025's financial structure has changed over time.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent40.27
Marketable Securities, Current SH0.00
Cash & Short-term Investments40.00
Other Receivables0.03
Other Current Assets25.36
Prepaid Expense And Other Assets Current1.63
Total Current Assets67.29
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent1.63
Tax Incentive Receivable Current-
Total Assets68.92
Liabilities
Accounts Payable, Current AC0.69
Accrued Royalties0.00
Derivative Liability, Current DE0.00
Other Liabilities, Current7.79
Taxes Payable, Current, Total0.38
Deferred Revenue, Current DE0.00
Total Current Liabilities8.87
Other Long-term Debt, Noncurrent OT0.09
Total Long-term Debt0.09
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent0.00
Accrued Expenses And Other Current Liabilities5.58
Operating Lease Liability Noncurrent0.94
Total Liabilities9.90
Stockholders' Equity
Common Stock Value0.06
Additional Paid In Capital Common Stock510.03
Retained Earnings / Accumulated Deficit-451.07
Other Equity0.00
Common Stockholder's Equity59.02
Preferred Stockholder's Equity0.00
Total Stockholder's Equity59.02
Liabilities & Stockholder's Equity68.92
4 historic quarters locked

Sign in to unlock the full Spero Therapeutics Inc balance sheet history.

About Spero Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-126192

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.